| Generic name | Bleomycin |
| Pronunciation | blee-oh-MY-sin |
| Brand name(s), other common name(s) | Blenoxane® |
| Drug type | Antitumor antibiotic |
| How the drug is given | Intravenously (IV) or by intramuscular (IM) or subcutaneous (SC) injection |
Indications and Usage
Bleomycin is FDA approved as a single agent or in proven combinations to treat people who have Hodgkin and non-Hodgkin lymphoma. Bleomycin may cause a temporary loss of hair in some people. Normal hair growth should return after treatment ends (although it may take several months).
Side effects needing medical attention
Cough; shortness of breath.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.